Genmab A/S Files March 2025 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Mar 10, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, registration-statement
TL;DR
Genmab filed its March 6-K, incorporating it into existing S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on March 10, 2025, to report information for the month of March 2025. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing serves as an update for investors and indicates ongoing reporting requirements for Genmab A/S, potentially related to its employee stock plans.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that incorporates previous filings and does not appear to contain new material financial or operational information.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, for the month of March 2025.
Which registration statements does this 6-K filing get incorporated into?
This 6-K filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the filing date of this Form 6-K?
The filing date is March 10, 2025.
What is the principal executive office address for Genmab A/S?
The principal executive office address is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Does Genmab A/S file annual reports under Form 20-F or 40-F?
Genmab A/S indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 10, 2025 regarding GENMAB A/S (GNMSF).